Related articles:
Antidepressant
Attention-deficit hyperactivity disorder
Eli Lilly and Company
Norepinephrine
Norepinephrine reuptake inhibitor
Stimulant
Key terms:
abuse
adhd
adolescents
atomoxetine
benefit
body mass
children
clinical
clinical trial
cocaine
depression
discontinuation
disorder
doses
effects
eli lilly
eli lilly and company
gradual
hydrochloride
hyperactivity
increase
label
manufactured
medications
mg
norepinephrine
overdose
patent
patients
pharmaceuticals
placebo
potential
psychiatric
reactions
regulatory
reported
reuptake inhibitor
risk
side effects
stimulants
strattera
studies
subsequently
symptoms
taking
thoughts
treatment
trial
warning
weeks
Search external links cited by footnotes on Wikipedia page Atomoxetine:
|
|